These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 18640620)
1. Tackling the epigenome in the pluripotent stem cells. Zhao X; Ruan Y; Wei CL J Genet Genomics; 2008 Jul; 35(7):403-12. PubMed ID: 18640620 [TBL] [Abstract][Full Text] [Related]
2. The epigenome in pluripotency and differentiation. Thiagarajan RD; Morey R; Laurent LC Epigenomics; 2014 Feb; 6(1):121-37. PubMed ID: 24579950 [TBL] [Abstract][Full Text] [Related]
3. [The alchemy--epigenetic regulation of pluripotency]. Bem J; Grabowska I Postepy Biochem; 2013; 59(2):144-56. PubMed ID: 24044279 [TBL] [Abstract][Full Text] [Related]
4. Histone acetylation and chromatin signature in stem cell identity and cancer. Shukla V; Vaissière T; Herceg Z Mutat Res; 2008 Jan; 637(1-2):1-15. PubMed ID: 17850830 [TBL] [Abstract][Full Text] [Related]
6. Formation of an active tissue-specific chromatin domain initiated by epigenetic marking at the embryonic stem cell stage. Szutorisz H; Canzonetta C; Georgiou A; Chow CM; Tora L; Dillon N Mol Cell Biol; 2005 Mar; 25(5):1804-20. PubMed ID: 15713636 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation of genes during development: a conserved theme from flies to mammals. Vasanthi D; Mishra RK J Genet Genomics; 2008 Jul; 35(7):413-29. PubMed ID: 18640621 [TBL] [Abstract][Full Text] [Related]
8. Dynamic chromatin states in human ES cells reveal potential regulatory sequences and genes involved in pluripotency. Hawkins RD; Hon GC; Yang C; Antosiewicz-Bourget JE; Lee LK; Ngo QM; Klugman S; Ching KA; Edsall LE; Ye Z; Kuan S; Yu P; Liu H; Zhang X; Green RD; Lobanenkov VV; Stewart R; Thomson JA; Ren B Cell Res; 2011 Oct; 21(10):1393-409. PubMed ID: 21876557 [TBL] [Abstract][Full Text] [Related]
9. A regulatory circuitry locking pluripotent stemness to embryonic stem cell: Interaction between threonine catabolism and histone methylation. Chen G; Wang J Semin Cancer Biol; 2019 Aug; 57():72-78. PubMed ID: 30710616 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of telomere chromatin integrity in pluripotent embryonic stem cells. Wong LH Epigenomics; 2010 Oct; 2(5):639-55. PubMed ID: 22122049 [TBL] [Abstract][Full Text] [Related]
11. Programmable genetic switches to control transcriptional machinery of pluripotency. Pandian GN; Sugiyama H Biotechnol J; 2012 Jun; 7(6):798-809. PubMed ID: 22588775 [TBL] [Abstract][Full Text] [Related]
12. Concise review: epigenetic mechanisms contribute to pluripotency and cell lineage determination of embryonic stem cells. Gan Q; Yoshida T; McDonald OG; Owens GK Stem Cells; 2007 Jan; 25(1):2-9. PubMed ID: 17023513 [TBL] [Abstract][Full Text] [Related]
13. Genome-wide epigenetic analysis of human pluripotent stem cells by ChIP and ChIP-Seq. Hitchler MJ; Rice JC Methods Mol Biol; 2011; 767():253-67. PubMed ID: 21822881 [TBL] [Abstract][Full Text] [Related]
15. Epigenetics in embryonic stem cells: regulation of pluripotency and differentiation. Atkinson S; Armstrong L Cell Tissue Res; 2008 Jan; 331(1):23-9. PubMed ID: 18004593 [TBL] [Abstract][Full Text] [Related]
16. Global epiproteomic signatures distinguish embryonic stem cells from differentiated cells. Dai B; Rasmussen TP Stem Cells; 2007 Oct; 25(10):2567-74. PubMed ID: 17641388 [TBL] [Abstract][Full Text] [Related]
17. Chromatin features and the epigenetic regulation of pluripotency states in ESCs. Tee WW; Reinberg D Development; 2014 Jun; 141(12):2376-90. PubMed ID: 24917497 [TBL] [Abstract][Full Text] [Related]
18. Genetic and epigenetic regulators of pluripotency. Surani MA; Hayashi K; Hajkova P Cell; 2007 Feb; 128(4):747-62. PubMed ID: 17320511 [TBL] [Abstract][Full Text] [Related]
19. Epigenetic Regulation of Transition Among Different Pluripotent States: Concise Review. Geng T; Zhang D; Jiang W Stem Cells; 2019 Nov; 37(11):1372-1380. PubMed ID: 31339608 [TBL] [Abstract][Full Text] [Related]
20. Using ChIP-based technologies to identify epigenetic modifications in disease-relevant cells. Falk J IDrugs; 2010 Mar; 13(3):169-74. PubMed ID: 20191433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]